Digital Psychological App Tested for People With Chronic Skin Conditions
Tests a phone app of psychological strategies in people with eczema, psoriasis or urticaria.
Plain-language title generated from the registry record
Registry title: Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Key facts
- Where
- Singapore, SingaporeSee the site
Where in Singapore
- National University HospitalSingapore, SingaporeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National University Hospital, Singapore
- Trial code
- NCT06702293
- Record updated
- 28 September 2026
- Original description
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.Read full original descriptionShow less
Development and Testing of a Digital Psychological Tool to Improve Symptom Burden in Dermatology Patients
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.
Inclusion: Patients with psoriasis, eczema or chronic urticaria diagnosed by a dermatologist; Aged 16 or older; Peak pruritus intensity of 4 or more on a 11-point numerical rating scale (0-10, with 10 representing worst itch); Able to engage with a mobile application in the English language.
Exclusion: Patients with unstable psychiatric condition, characterized by; o Hospital inpatient admission for a psychiatric condition or initiation of a psychotropic medication in the prior 3 months; Patients with active psychiatric symptoms (e.g. active suicidal ideation, psychosis, delusions); Patients with unstable dermatological condition, characterized by; Recent flare of the skin condition within the last 2 weeks, including diagnosis of a flare by a doctor, use of systemic steroids, oral antibiotics, wet wrap rescue therapy, oral antivirals, or increase in frequency of phototherapy or dose of systemic medications for the dermatological condition within the last 2 weeks OR; Any of the following within 3 months; inpatient admission for a dermatological condition; Initiation of phototherapy; Initiation of systemic therapy (conventional immunosuppressive agent, biologics, JAK inhibitors) within the last 3 months.